Separate names with a comma.
Discussion in 'NeurogesX' started by Anonymous, Jan 17, 2010 at 3:33 PM.
Um, oh shit.
Does Tim Byrns work for this company?
Any word on Long Island? What are the expectations of the company as far as sales? Any idea on average bonus, if any? I appreciate all the negative comments. It shows me this company is just like everyone else, but what's the deal? The new code is great, but how about admin coding? Any input would be appreciated.
I heard there are positions open. Are they expanding or is turnover really high?
With the product failing miserably, have they started to scapegoat reps yet?
What's the status of this company? split between accepting an offer or sticking with a pharma company
Do you have any news regarding
- How is the mood inside Neurogesx after the recent reduction in personnel (especially reps)
- Is the new sales territory distribution sound to you?
- What do you know regarding the replacement of Tony, the CEO?
- Are there still rumours about J&J acquisition?
Hi all! ANyone has an info, a thought, an insider, on this?
Run Like Hell. Stay at your current job.
They just laid off reps ranking in the top 10 and closed territories in the top 10.
The entire sales force is looking for a job. If the job market was better the majority of reps would have already left.
that really sucks. Appreciate your feedback.
Just one question - i hear that in a couple of weeks they will get a new CEO. Is there hope that the new "boss" could bring some positive path to the company?
Lay off's due to a new indication where there may not be any HIV? Just a thought. Maybe everyone should pipe down and relax and watch football or something.
NGSX is not going anywhere, we have a long patent life and plenty of money, new CEO coming, etc. I am just going to keep selling and not worry about it. You people need psych meds.
Glad we got rid of alot of the reps that were negative, not selling and bitching about everything. Go back to big pharma and hide where you belong or some crap home office job.
What's the stock price?